Detection and Management of Intraocular Inflammation after Brolucizumab Treatment for Neovascular Age-Related Macular Degeneration

被引：0
|
作者：
Bodaghi, Bahram
Souied, Eric H.
Tadayoni, Ramin
Weber, Michel
Ponthieux, Anne
Kodjikian, Laurent
机构：
来源：
OPHTHALMOLOGY | 2023年 / 130卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：1106 / 1106
页数：1
相关论文
共 50 条
  • [31] Real-world frequency and outcomes of intraocular inflammation-related adverse events in eyes with neovascular age-related macular degeneration treated with brolucizumab
    Mccoy, Jasmyne E.
    Zubricky, Ryan
    Donkor, Richard
    Miller, David G.
    Sonbolian, Nina
    Heaney, Andrew
    Bilano, Ver
    Karcher, Helene
    Coney, Joseph M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [32] Brolucizumab Use in Treatment Resistant Neovascular Age Related Macular Degeneration (nAMD)
    Shortell, Justin
    Hill, Christine
    Thomas, Claire
    Peck, Travis
    Melamud, Alexander
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [33] Brolucizumab (Beovu) for Age-Related Macular Degeneration
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1591): : 23 - 24
  • [34] Three-year visual outcomes after brolucizumab in patients with neovascular age-related macular degeneration
    Yume Kobayashi
    Maiko Maruyama-Inoue
    Tatsuya Inoue
    Yasuo Yanagi
    Kazuaki Kadonosono
    BMC Ophthalmology, 25 (1)
  • [35] Guidance for the treatment of neovascular age-related macular degeneration
    Schmidt-Erfurth, Ursula M.
    Richard, Gisbert
    Augustin, Albert
    Aylward, William G.
    Bandello, Francesco
    Corcostegui, Borja
    Cunha-Vaz, Jose
    Gaudric, Alain
    Leys, Anita
    Schlingemann, Rainier O.
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2007, 85 (05): : 486 - 494
  • [36] A CONSENSUS ON RISK MITIGATION FOR BROLUCIZUMAB IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Patient Selection, Evaluation, and Treatment
    Holz, Frank G.
    Iida, Tomohiro
    Maruko, Ichiro
    Sadda, Srinivas R.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2022, 42 (09): : 1629 - 1637
  • [37] Brolucizumab: A Newly Developed Anti-VEGF Molecule for the Treatment of Neovascular Age-Related Macular Degeneration
    Tadayoni, Ramin
    Sararols, Laura
    Weissgerber, Georges
    Verma, Rohini
    Clemens, Andreas
    Holz, Frank G.
    OPHTHALMOLOGICA, 2021, 244 (02) : 93 - 101
  • [38] Bevacizumab for the Treatment of Neovascular Age-Related Macular Degeneration
    Pitlick, Jamie M.
    Vecera, Kayla F.
    Barnes, Kylie N.
    Reski, John W.
    Forinash, Alicia B.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (02) : 290 - 296
  • [39] TREATMENT PATTERNS OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Dugel, P. U.
    Arnold, R. J.
    Layton, A. J.
    VALUE IN HEALTH, 2014, 17 (03) : A149 - A149
  • [40] AFLIBERCEPT FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Verner-Cole, E. A.
    Davis, S. J.
    Lauer, A. K.
    DRUGS OF TODAY, 2012, 48 (05) : 317 - 329
12345